Company intelligence / Profile preview

Trellus Health

New York City, New York, United Statestrellushealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Trellus Health's proprietary resilience-driven approach has demonstrated significant clinical outcomes in IBD patients, including a 71% reduction in emergency department visits, 94% reduction in unplanned hospitalizations, 49% reduction in opioid use, and 73% reduction in corticosteroid use after one year, validated by Mount Sinai research.

Therapeutic areas: GastroenterologyPsychiatry
Modalities: Non-pharmacological therapyDigital health platformBehavioral intervention
Industry: Digital Health Medical Devices

Partnerships

Johnson & JohnsonPfizer

Beyond the preview

Go deeper on Trellus Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trellus Health.

Explore the full profile